Drug Profile
SXL 05 - Selexel
Alternative Names: SXL05Latest Information Update: 19 Sep 2023
Price :
$50
*
At a glance
- Originator SeleXel
- Class Antineoplastics; Small interfering RNA
- Mechanism of Action RNA interference; Small interfering RNA modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Breast cancer; Prostate cancer
Most Recent Events
- 19 Sep 2023 Discontinued - Preclinical for Breast cancer in France (Parenteral)
- 19 Sep 2023 Discontinued - Preclinical for Prostate cancer in France (Parenteral)
- 28 Oct 2020 No recent reports of development identified for preclinical development in Breast-cancer in France (Parenteral)